Tactile Systems Technology, Inc. TCMD

FY2025 · ended Dec 31, 2025 · Revenue $329.52M, +12.5% YoY · Filed Feb 17, 2026

Tactile Systems Technology, Inc. (TCMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $329.5 million and net income of $19.1 million. Free cash flow was $40.4 million. As of Sep 30, 2026 it held $75.1 million in cash and investments and $17.1 million in total debt.

Revenue (TTM)
$356.42M
+14.4% vs year-ago TTM
Net income (TTM)
$23.82M
+31.1% vs year-ago TTM
Operating cash flow (TTM)
$32.19M
-23.1% vs year-ago TTM
Free cash flow (TTM)
$29.02M
-26.6% vs year-ago TTM
EPS (TTM)
$1.03
+33.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
22.44M
-4.9% vs prior year
Net cash
$58.04M
as of Sep 30, 2026
Operating margin
9.4%
FY 2026

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TCMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MN
Headquarters
Minneapolis, MN
SEC filer status
Accelerated filer
SEC CIK
1027838

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$329.5M
$293.0M
$274.4M
$246.8M
$208.1M
Operating income
$29.3M
$22.2M
$18.0M
-$12.8M
-$1.8M
Net income
$19.1M
$17.0M
$28.5M
-$17.9M
-$11.8M
Diluted EPS
$0.82
$0.70
$1.23
-$0.89
-$0.60
Operating cash flow
$42.8M
$40.7M
$35.9M
$5.2M
$2.6M
Free cash flow
$40.4M
$38.3M
$33.5M
$3.4M
$528,000
Total assets
$273.9M
$297.9M
$281.4M
$255.0M
$244.3M
Total liabilities
$55.0M
$81.3M
$87.8M
$133.6M
$116.0M
Stockholders' equity
$218.9M
$216.6M
$193.6M
$121.4M
$128.2M
Cash and investments
$83.4M
$94.4M
$61.0M
$21.9M
$28.2M
Total debt
$16.0M
$18.9M
$21.2M
$23.4M
$25.9M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q/A Amended quarterly report Nov 3, 2026 Jun 30, 2026
10-Q/A Amended quarterly report Nov 3, 2026 Sep 30, 2025
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.